A record built quietly.

Secured over US$10 million in initial orders. 2026 revenue target: US$100 million.

Delivering a fully tailor-made program built around two pillars — an upcoming intelligent driving technical validation project and a market audit event — backed by regulatory approval, in-country logistics, and multi-stakeholder coordination, while accompanying the vehicle's licensing process throughout, for the manufacturer's new model introduction in Israel.

Supported a commercial agreement with a total deal value of US$15 million.

Delivered a fully independent view of the target's technology readiness, execution risk, and capital requirements, enabling a well-informed decision.

Delivered Arthouse Advisory direct, qualified access to a curated network of high-net-worth Israeli collectors, family offices, and investors — establishing a credible foothold in a market where the firm had no prior presence or relationships.

Secured evaluation by Herzliya Medical Center (HMC), Israel's largest private hospital with over 5,000 employees, of Dajing Medical's endoscopic camera systems — delivered through regulatory groundwork, due diligence, and negotiations conducted entirely on the company's behalf, in a market where it had no distributor, no prior sales, and no existing contacts.

Delivered structured market intelligence and pre-qualified engagement opportunities, materially reducing time-to-first-engagement.